Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Rapid Fluorescence Fingerprinting Assay for Identification of Synthetic Cannabinoid Receptor Agonists

By LabMedica International staff writers
Posted on 14 Nov 2019
A team of British researchers developed a rapid real-time, point-of-care test for the identification of synthetic cannabinoid receptor agonists (SCRAs), a class of illegal drugs known colloquilly as “Spice” or “K2”.

SCRAs are a family of compounds designed to mimic the effects of tetrahydrocannabinol (THC) and cannabidiol (CBD), the psychoactive molecules in cannabis, by binding to CB1 and CB2 cannabinoid receptors and acting as agonists for receptor function. More...
CB1 receptors are most commonly found in the peripheral and central nervous system, while the structurally smaller CB2 receptors are mostly expressed within the immune system. Under normal endogenous conditions, these cannabinoid receptors have been found to modulate a variety of physiological and cognitive processes including fertility, pregnancy, pre- and postnatal development, appetite, pain sensation, inflammation, mood, and memory, causing a number of major side effects, both psychological and physiological. These include, but are not limited to, acute kidney injury, vomiting, cardiovascular complications, agitation, irritability, confusion, hallucinations, delusions, psychosis, and even death. The severity of these side effects are thought to be due to SCRAs having unusually high binding affinities at CB receptors, coupled with acting as full agonists of CB receptors.

SCRAs are highly potent and addictive drugs that are prevalent in the prison system and among homeless populations in the United Kingdom. SCRAs are chemically diverse, with over a hundred compounds used as recreational drugs. The chemical diversity of SCRA structures presents a challenge in developing techniques to detect them. Typically, GC-MS is used for chemical identification; however, this technology is not usually available in most settings where detection is critical, such as in hospital emergency rooms, in jails or prisons, or among homeless communities.

In this light, investigators at the University of Bath (United Kingdom) sought to develop a real time, point-of-care method for identification of SCRAs.

In a recent paper, they reported that fluorescence spectral fingerprinting, which required only about five minutes to perform, could be used to identify the likely presence of SCRAs, as well as provide more specific information on structural class and concentration. Furthermore, the investigators demonstrated that that fluorescence spectral fingerprints, combined with numerical modeling, could detect both parent and burnt material, and that such fingerprinting was also practical for detecting them in saliva.

Senior author Dr. Chris Pudney, senior lecturer in biology and biochemistry at the University of Bath, said, "My partner is a psychiatrist and she was telling me that currently they do not have a way to confirm when they suspect spice use, they just do not know for sure. You can test for it with a urine or blood sample that is sent off to a lab, but that takes a few days and so in most cases it's pointless. I started looking into the chemistry and it is actually similar to something we have developed for detection of biological molecules. We decided on saliva because it seemed tractable and less invasive than some other options. We have proved the concept with a test that is simple and very accurate. The hardware is compact and portable and the results are easy to understand. We are working on software now, so that the user has a simple “one click” way to use it."

The fluorescence fingerprinting method was described in the September 5, 2019, issue of the journal Analytical Chemistry.

Related Links:
University of Bath


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Laboratory Software
ArtelWare
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.